Human Longevity and Insilico Medicine announced a collaboration to develop foundation models for longevity science.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Human Longevity and Insilico Medicine announced a collaboration to develop foundation models for longevity science.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Insilico Medicine is conducting a Phase I study in Australia, and Feng Ren serves as Co-CEO and Chief Scientific Officer.Sub-event
The two companies are collaborating on longevity science models and analyzing the global market.1 source
Keep exploring
The entities involved
-
Human Longevity
company in San Diego, United States
Nothing else this week.
-
Insilico Medicine
American biotechnology company
Nothing else this week.